In a report, the regulator sharply criticized pharmacy benefit managers, a reversal from its longstanding hands-off approach to policing the companies.

  • catloaf@lemm.ee
    link
    fedilink
    English
    arrow-up
    17
    arrow-down
    1
    ·
    10 months ago

    Shame that they probably can’t do anything about it with the Chevron decision.

    • Flying Squid@lemmy.world
      link
      fedilink
      arrow-up
      8
      arrow-down
      3
      ·
      10 months ago

      Don’t worry, I was told here on Lemmy after SCOTUS struck down Chevron that putting these sort of things in the hands of the judiciary was a good idea.

      I’m curious if the people who insisted that felt the same way after SCOTUS also said that the president can commit crimes?

  • bean@lemmy.world
    link
    fedilink
    arrow-up
    2
    arrow-down
    1
    ·
    10 months ago

    An investigation by The New York Times published last month found that the benefit managers often act in their own interests, at the expense of patients, employers and taxpayers.

    So shocked. 🙄 Why it takes so many years for them to notice or do anything.